Cite
Isolation of nanobodies with potential to reduce patients' IgE binding to Bet v 1.
MLA
Zettl, Ines, et al. “Isolation of Nanobodies with Potential to Reduce Patients’ IgE Binding to Bet v 1.” Allergy, vol. 77, no. 6, June 2022, pp. 1751–60. EBSCOhost, https://doi.org/10.1111/all.15191.
APA
Zettl, I., Ivanova, T., Strobl, M. R., Weichwald, C., Goryainova, O., Khan, E., Rutovskaya, M. V., Focke, T. M., Drescher, A., Bohle, B., Flicker, S., & Tillib, S. V. (2022). Isolation of nanobodies with potential to reduce patients’ IgE binding to Bet v 1. Allergy, 77(6), 1751–1760. https://doi.org/10.1111/all.15191
Chicago
Zettl, Ines, Tatiana Ivanova, Maria R. Strobl, Christina Weichwald, Oksana Goryainova, Evgenia Khan, Marina V. Rutovskaya, et al. 2022. “Isolation of Nanobodies with Potential to Reduce Patients’ IgE Binding to Bet v 1.” Allergy 77 (6): 1751–60. doi:10.1111/all.15191.